HomeInsights

Debasis Nandy Board Membership

Debasis Nandy Board Membership

Last Updated on: Nov 23, 2024

About Debasis Nandy

  • Debasis Nandy was appointed as an Independent Director of Jagsonpal Pharmaceuticals Ltd on June 29, 2022, and his appointment was confirmed at the Annual General Meeting held on September 14, 2022.
  • He serves on the Board alongside other industry experts and chairs the Audit Committee, contributing his extensive experience and expertise in finance and corporate governance to the company.

List of Companies Associated with Debasis Nandy

Company Name
leftPosition Heldright
Jagsonpal Pharmaceuticals LtdIndependent Director

Historical Share prices

* All values are in Rupees

Debasis Nandy Sector Specific Experience

About Debasis Nandy's work experience

  • Debasis Nandy is currently a Independent Director in Jagsonpal Pharmaceuticals Ltd (as of Mar 2024).
  • Debasis Nandy is serving the company - Jagsonpal Pharmaceuticals Ltd at this position since 2023 for the last 2+ years.
  • Debasis Nandy was Independent Director of Jagsonpal Pharmaceuticals Ltd for 3 years from 2022 to 2024.

FAQ's related Debasis Nandy

Who is Debasis Nandy

Debasis Nandy was appointed as an Independent Director of Jagsonpal Pharmaceuticals Ltd on June 29, 2022, and his appointment was confirmed at the Annual General Meeting held on September 14, 2022. He serves on the Board alongside other industry experts and chairs the Audit Committee, contributing his extensive experience and expertise in finance and corporate governance to the company.

Which companies does Debasis Nandy serve as a board member for?

Debasis Nandy serves as a board member for: Jagsonpal Pharmaceuticals Ltd

What positions has Debasis Nandy held in his/her career?

Throughout their career, Debasis Nandy has held key positions such as Independent Director, contributing to the growth and success of each company.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
up arrow
50yearstrust

Unlimited trading at just

Rs. 399

Rs. 199*